Two Sigma Securities’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-12,624
| Closed | -$61K | – | 1371 |
|
|
2022
Q2 | $61K | Buy |
+12,624
| New | +$61K | ﹤0.01% | 863 |
|
|
2020
Q3 | – | Sell |
-1,242
| Closed | -$13K | – | 522 |
|
|
2020
Q2 | $13K | Buy |
1,242
+785
| +172% | +$8.22K | ﹤0.01% | 526 |
|
|
2020
Q1 | $3K | Buy |
457
+81
| +22% | +$532 | ﹤0.01% | 588 |
|
|
2019
Q4 | $2K | Buy |
+376
| New | +$2K | ﹤0.01% | 744 |
|
|
2019
Q3 | – | Sell |
-878
| Closed | -$6K | – | 733 |
|
|
2019
Q2 | $6K | Buy |
878
+393
| +81% | +$2.69K | ﹤0.01% | 829 |
|
|
2019
Q1 | $7K | Sell |
485
-210
| -30% | -$3.03K | ﹤0.01% | 783 |
|
|
2018
Q4 | $8K | Sell |
695
-513
| -42% | -$5.91K | ﹤0.01% | 1078 |
|
|
2018
Q3 | $27K | Buy |
1,208
+826
| +216% | +$18.5K | ﹤0.01% | 1033 |
|
|
2018
Q2 | $7K | Buy |
+382
| New | +$7K | ﹤0.01% | 1012 |
|
|
2018
Q1 | – | Sell |
-692
| Closed | -$14K | – | 1165 |
|
|
2017
Q4 | $14K | Buy |
692
+100
| +17% | +$2.02K | ﹤0.01% | 952 |
|
|
2017
Q3 | $10K | Buy |
+592
| New | +$10K | ﹤0.01% | 820 |
|
|
2017
Q2 | – | Sell |
-433
| Closed | -$20K | – | 855 |
|
|
2017
Q1 | $20K | Sell |
433
-700
| -62% | -$32.3K | ﹤0.01% | 842 |
|
|
2016
Q4 | $30K | Buy |
1,133
+709
| +167% | +$18.8K | 0.01% | 630 |
|
|
2016
Q3 | $17K | Buy |
+424
| New | +$17K | 0.01% | 610 |
|